Max Robotics — Global Service Robot Directory + US Certification

About

S. Jacob Scheinerman is a cardiothoracic surgeon whose research sits at the intersection of minimally invasive cardiac surgery and innovative thoracic interventions. His work has made significant contributions to two distinct but complementary fields: coronary revascularization and the surgical management of tracheobronchomalacia. Scheinerman is perhaps best recognized for pioneering robot-assisted tracheobronchoplasty (TBP), leading the first reported series of this procedure for severe tracheobronchomalacia — a progressive and debilitating airway disease. That landmark 2018 paper has accumulated 47 citations, with subsequent studies demonstrating durable improvements in both quality of life and pulmonary function on intermediate follow-up, cementing robotic TBP as a credible minimally invasive alternative to open surgery. In cardiac surgery, Scheinerman has been a consistent advocate for minimally invasive coronary bypass, including hybrid coronary revascularization (HCR) and minimally invasive direct coronary artery bypass (MIDCAB). His longitudinal analyses — spanning outcomes over 25 years and more than 2,000 patients — underscore the safety and evolution of these techniques. With a growing citation record across seven major publications, Scheinerman's research offers students and clinicians alike a rigorous evidence base for advancing less invasive approaches to complex surgical problems.